{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/348601647"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Research costs (3) In determining under section 83 whether a medicine is being or has been sold in any market in Canada at an excessive price, the Board shall not take into consideration research costs other than the Canadian portion of the world costs related to the research that led to the invention pertaining to that medicine or to the development and commercialization of that invention, calcul" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "wipo.int" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/342928197"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/348601647"] } } }
